Chang-Te Lin

498 total citations
30 papers, 345 citations indexed

About

Chang-Te Lin is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Archeology. According to data from OpenAlex, Chang-Te Lin has authored 30 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 12 papers in Pediatrics, Perinatology and Child Health and 6 papers in Archeology. Recurrent topics in Chang-Te Lin's work include Kidney Stones and Urolithiasis Treatments (14 papers), Pediatric Urology and Nephrology Studies (12 papers) and Paleopathology and ancient diseases (6 papers). Chang-Te Lin is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (14 papers), Pediatric Urology and Nephrology Studies (12 papers) and Paleopathology and ancient diseases (6 papers). Chang-Te Lin collaborates with scholars based in Taiwan. Chang-Te Lin's co-authors include Yeong‐Chin Jou, Pi-Che Chen, Ming-Chin Cheng, Cheng‐Huang Shen, Deching Chang, Cheng‐Da Hsu, Hsiao‐Yen Hsieh, Shu-Fen Wu, Yi‐Wen Liu and Chorng‐Shyan Chern and has published in prestigious journals such as The Journal of Urology, Cancer Letters and Urology.

In The Last Decade

Chang-Te Lin

28 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang-Te Lin Taiwan 11 182 134 70 49 49 30 345
Yunkai Zhu China 11 160 0.9× 26 0.2× 73 1.0× 11 0.2× 38 0.8× 30 344
Jun Ouyang China 12 112 0.6× 21 0.2× 94 1.3× 135 2.8× 16 0.3× 43 375
Weijie Zhu China 11 75 0.4× 83 0.6× 178 2.5× 69 1.4× 125 2.6× 36 407
Viktoria Stühler Germany 12 157 0.9× 12 0.1× 139 2.0× 71 1.4× 20 0.4× 34 308
Jennifer Linehan United States 10 87 0.5× 11 0.1× 77 1.1× 277 5.7× 167 3.4× 25 409
Guangcheng Dai China 12 155 0.9× 9 0.1× 185 2.6× 44 0.9× 41 0.8× 31 376
David Slosky United States 10 89 0.5× 13 0.1× 135 1.9× 44 0.9× 5 0.1× 18 336
Shuqiu Chen China 9 126 0.7× 5 0.0× 217 3.1× 50 1.0× 14 0.3× 30 375
Youkyoung Lee South Korea 7 100 0.5× 4 0.0× 104 1.5× 116 2.4× 4 0.1× 14 346
Salvatore Parisi Italy 11 59 0.3× 6 0.0× 156 2.2× 63 1.3× 3 0.1× 38 369

Countries citing papers authored by Chang-Te Lin

Since Specialization
Citations

This map shows the geographic impact of Chang-Te Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang-Te Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang-Te Lin more than expected).

Fields of papers citing papers by Chang-Te Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang-Te Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang-Te Lin. The network helps show where Chang-Te Lin may publish in the future.

Co-authorship network of co-authors of Chang-Te Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chang-Te Lin. A scholar is included among the top collaborators of Chang-Te Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang-Te Lin. Chang-Te Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Kyu Hyun, et al.. (2025). Intraoperative stone culture for tubeless minipercutaneous nephrolithotomy. Urological Science. 36(2). 83–88.
2.
Shen, Cheng‐Huang, et al.. (2022). Sunitinib-related high-grade proteinuria and allograft dysfunction in a kidney recipient: a rare case report. BMC Nephrology. 23(1). 150–150. 2 indexed citations
3.
Jou, Yeong‐Chin, et al.. (2020). Tubeless Mini-Percutaneous Nephrolithotomy for the Treatment of Renal and Upper Ureteral Stones of ≥3 cm in Diameter. Urological Science. 31(2). 68–72. 2 indexed citations
4.
Lin, Chang-Te, et al.. (2017). One day hospitalization for trans-rectal ultrasound guided prostate biopsy: Experiences of a single institution. Urological Science. 28(4). 235–239. 1 indexed citations
5.
Shen, Cheng‐Huang, et al.. (2016). Evaluation of urinary bladder fibrogenesis in a mouse model of long-term ketamine injection. Molecular Medicine Reports. 14(3). 1880–1890. 19 indexed citations
6.
Yeh, Chia‐Ming, Pi-Che Chen, Hsiao‐Yen Hsieh, et al.. (2015). Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma. Oncotarget. 6(30). 29555–29572. 37 indexed citations
7.
Jou, Yeong‐Chin, Cheng‐Huang Shen, Ming-Chin Cheng, Chang-Te Lin, & Pi-Che Chen. (2012). Bilateral ureteral complete obstruction with huge spontaneous urinoma formation in a patient with advanced bladder cancer. Journal of the Chinese Medical Association. 75(2). 84–86. 8 indexed citations
8.
Shen, Cheng-Huang, Hsiao‐Yen Hsieh, Yuan‐Hung Wang, et al.. (2010). High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma. Experimental and Therapeutic Medicine. 1(5). 893–898. 13 indexed citations
9.
Lin, Chang-Te, Yeong‐Chin Jou, Ming-Chin Cheng, Cheng‐Huang Shen, & Pi-Che Chen. (2009). Delayed Hydrothorax after Percutaneous Nephrolithotomy: Case Report. 20(4). 190–191. 2 indexed citations
10.
Lin, Chang-Te, Chin Li, Cheng‐Huang Shen, et al.. (2009). Dysfunction of natural killer cells in patients with transitional cell carcinoma. Cancer Letters. 291(1). 39–45. 6 indexed citations
11.
Jou, Yeong‐Chin, Chang-Te Lin, Cheng‐Huang Shen, Ming-Chin Cheng, & Pi-Che Chen. (2009). Tubeless Percutaneous Nephrolithotomy for Geriatric Patients. Urologia Internationalis. 82(3). 346–349. 13 indexed citations
12.
Jou, Yeong‐Chin, et al.. (2008). Hyperbaric Oxygen Therapy for Cyclophosphamide-induced Intractable Refractory Hemorrhagic Cystitis in a Systemic Lupus Erythematosus Patient. Journal of the Chinese Medical Association. 71(4). 218–220. 6 indexed citations
13.
Jou, Yeong‐Chin, Cheng‐Huang Shen, Ming-Chin Cheng, Chang-Te Lin, & Pi-Che Chen. (2007). High-Power Holmium:Yttrium-Aluminum-Garnet Laser for Percutaneous Treatment of Large Renal Stones. Urology. 69(1). 22–25. 17 indexed citations
14.
Shen, Cheng‐Huang, Ming-Chin Cheng, Chang-Te Lin, Yeong‐Chin Jou, & Pi-Che Chen. (2007). Innovative Metal Dilators for Percutaneous Nephrostomy Tract: Report on 546 Cases. Urology. 70(3). 418–421. 5 indexed citations
15.
Jou, Yeong‐Chin, et al.. (2006). Nephrostomy tube-free percutaneous nephrolithotomy for patients with large stones and staghorn stones. Urology. 67(1). 30–34. 23 indexed citations
16.
Jou, Yeong‐Chin, et al.. (2005). Percutaneous nephrolithotomy with holmium: Yttrium-aluminum-garnet laser and fiber guider—report of 349 cases. Urology. 65(3). 454–458. 21 indexed citations
17.
Jou, Yeong‐Chin, et al.. (2004). Electrocauterization of bleeding points for percutaneous nephrolithotomy. Urology. 64(3). 443–446. 28 indexed citations
18.
Jou, Yeong‐Chin, et al.. (2004). Cauterization of Access Tract for Nephrostomy Tube-Free Percutaneous Nephrolithotomy. Journal of Endourology. 18(6). 547–549. 4 indexed citations
19.
Jou, Yeong‐Chin, et al.. (2004). Cauterization of Access Tract for Nephrostomy Tube-Free Percutaneous Nephrolithotomy. Journal of Endourology. 18(6). 547–549. 48 indexed citations
20.
Lin, Chang-Te, et al.. (1998). A simple means of making the differential diagnosis of ureterouterine and vesicouterine fistula.. PubMed. 160(4). 1420–1. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunkai Zhu Breakdown of academic impact, for papers by Jun Ouyang Breakdown of academic impact, for papers by Weijie Zhu Breakdown of academic impact, for papers by Viktoria Stühler Breakdown of academic impact, for papers by Jennifer Linehan Breakdown of academic impact, for papers by Guangcheng Dai Breakdown of academic impact, for papers by David Slosky Breakdown of academic impact, for papers by Shuqiu Chen Breakdown of academic impact, for papers by Youkyoung Lee Breakdown of academic impact, for papers by Salvatore Parisi
Rankless by CCL
2026